News

The company said it is using organoids – small lab-grown tissues that mimic human organ structures – and microphysiological ... SillaJen’s BAL0891, a first-in-class dual-targeting oncology drug, was ...
CRISPR-Cas9 is a powerful gene editing system that has revolutionized our ability to treat disease and probe the human genome. CRISPR has been used to edit the genomes of animals, plants, and microbes ...
Tim Andrews knew that he needed dialysis to manage his end-stage kidney disease, but over months of treatment, he started to wonder whether it was worth it. Desperate for another option, he found a ...
The 1980s saw the first genetically modified organisms and transgenic animals, while the 1990s brought the ambitious Human Genome Project. Also Read: Genetically engineered animals are here ...
A recent study marks the first reported instance of generative ... enzymes and antibodies faster than ever before. However, many human diseases stem from faulty gene expression that is cell ...
Bookmark stories for easy access on any device or the Swarajya app. India’s first human spaceflight programme, Gaganyaan, has entered its final phase, with the country’s first crewed space ...
As debates around AI intensify worldwide, Wikipedia’s human-first model offers a powerful counterpoint: that machines can augment human effort—but should not replace human judgment. The Wikimedia ...
WASHINGTON, D.C. — Human Rights First has filed a lawsuit against the Trump administration on behalf of the International Criminal Court (ICC) trial attorney and U.S. Army veteran Eric Iverson, ...
First pig-to-human heart transplant: what can scientists learn? The first genetically modified pig heart to be successfully transplanted into a living person was later found to be tainted with a ...
By connecting clues across time and geography, researchers are building what could become the first complete map of our shared human ancestry. Yet, the road to this goal has not been smooth.
Objective To evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary antitumour activity of AMG 404, a fully human IgG1 monoclonal antibody targeting programmed cell death-1, in ...